NASDAQ: GLUE

Stocks Trading

GLUE stock’s current quarter earnings estimates: What analysts predict?

Cameron Mitchell

Monte Rosa Therapeutics Inc (GLUE)’s stock has witnessed a price hike of 0.79% from the previous close with its current ...

Market Summary

Monte Rosa Therapeutics Inc (NASDAQ:GLUE): It’s all about numbers this morning

Preston Campbell

Monte Rosa Therapeutics Inc (GLUE)’s stock is trading at $6.46 at the moment marking a fall of -1.12% from the ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.